Literature DB >> 34158492

Author Correction: A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation.

Antonio E Muruato1,2, Camila R Fontes-Garfias1, Ping Ren3, Mariano A Garcia-Blanco1,4,5, Vineet D Menachery2,3,6, Xuping Xie7, Pei-Yong Shi8,9,10,11,12.   

Abstract

Entities:  

Year:  2021        PMID： 34158492      PMCID： PMC8218561          DOI： 10.1038/s41467-021-24287-2

Source DB:  PubMed          Journal:  Nat Commun        ISSN： 2041-1723            Impact factor:   14.919


× No keyword cloud information.
Correction to: Nature Communications 10.1038/s41467-020-17892-0, published online 13 August 2020. The original version of this Article contained an error in the Acknowledgements, which incorrectly listed the NIH grant ‘AI142759’. This has been corrected in both the PDF and HTML versions of the Article.
  3 in total

1.  The challenge of evaluating of SARS-CoV-2 antibody responses among vaccinated transplant patients.

Authors:  Taito Kitano; Aaron Campigotto; Upton Allen
Journal:  Pediatr Transplant       Date:  2022-05-26

2.  Sera of patients infected by earlier lineages of SARS-CoV-2 are capable to neutralize later emerged variants of concern.

Authors:  Alex Pauvolid-Corrêa; Braulia Costa Caetano; Ana Beatriz Machado; Mia Araújo Ferreira; Natalia Valente; Thayssa Keren Neves; Kim Geraldo; Fernando Motta; Valdiléa Gonçalves Veloso Dos Santos; Beatriz Grinsztejn; Marilda Mendonça Siqueira; Paola Cristina Resende
Journal:  Biol Methods Protoc       Date:  2022-08-22

3.  Persistence of SARS-CoV-2 neutralizing antibodies longer than 13 months in naturally infected, captive white-tailed deer (Odocoileus virginianus), Texas.

Authors:  Sarah A Hamer; Chase Nunez; Christopher M Roundy; Wendy Tang; Logan Thomas; Jack Richison; Jamie S Benn; Lisa D Auckland; Terry Hensley; Walter E Cook; Alex Pauvolid-Corrêa; Gabriel L Hamer
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 19.568
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.